ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Nanoparticle-Mediated CD47-SIRPα Blockade and Calreticulin Exposure for Improved Cancer Chemo-Immunotherapy

Luo, Jia-Qi; Liu, Rong; Chen, Fang-Man; Zhang, Jing-Yang; Zheng, Sui-Juan; Shao, Dan; Du, Jin-Zhi*
ACS Nano2023-5-3DOI: 10.1021/acsnano.2c08240
14被引3阅读
引用收藏
分享

摘要

Enabling macrophages to phagocytose tumor cells holds great potential for cancer therapy but suffers from tremendous challenges because the tumor cells upregulate antiphagocytosis molecules (such as CD47) on their surface. The blockade of CD47 alone is insufficient to stimulate tumor cell phagocytosis in solid tumors due to the lack of "eat me" signals. Herein, a degradable mesoporous silica nanoparticle (MSN) is reported to simultaneously deliver anti-CD47 antibodies (aCD47) and doxorubicin (DOX) for cancer chemo-immunotherapy. The codelivery nanocarrier aCD47-DMSN was constructed by accommodating DOX within the mesoporous cavity, while adsorbing aCD47 on the surface of MSN. aCD47 blocks the CD47-SIRP alpha axis to disable the "don't eat me" signal, while DOX induces immunogenic tumor cell death (ICD) for calreticulin exposure as an "eat me" signal. This design facilitated the phagocytosis of tumor cells by macrophages, which enhanced antigen cross-presentation and elicited efficient T cell-mediated immune response. In 4T1 and B16F10 murine tumor models, aCD47-DMSN generated a strong antitumor effect after intravenous injection by increasing tumor-infiltration of CD8+ T cells. Taken together, this study offers a nanoplatform to modulate the phagocytosis of macrophages for efficacious cancer chemo-immunotherapy.

学科与关键词

关键词
Macrophagephagocytosiseat medo not eat mechemo-immunotherapy
相关
加载中…
  • Nanoparticle-Enabled Dual Modulation of Phagocytic Signals to Improve Macrophage-Mediated Cancer Immunotherapy
    Zhang, Ya-Ru; Luo, Jia-Qi; Zhang, Jing-Yang; Miao, Wei-Min; Wu, Jia-Si; Huang, Hua; Tong, Qi-Song; Shen, Song; Leong, Kam W.; Du, Jin-Zhi*; Wang, JunSmall, 2020, 16(46): 2004240.被引 45
  • Nanoparticle-enabled concurrent modulation of phagocytosis and repolarization of macrophages for enhanced cancer immunotherapy
    Zhang, Jing-Yang; Chen, Fang -Man; Liu, Rong; Luo, Jia-Qi; Huang, Yong-Cong; Shu, Na; Zheng, Sui-Juan; Shao, Dan; Leong, Kam W.*; Du, Jin-Zhi*Nano Today, 2022, 47: 101651.被引 2
  • Nanoassembly of doxorubicin-conjugated polyphosphoester and siRNA simultaneously elicited macrophage- and T cell- mediated anticancer immune response for cancer therapy
    Li, Dongdong; Cao, Ziyang; Chen, Chaoran; Li, Hengyi; He, Shan; Hou, Xurui; Liang, Ming*; Yang, Xianzhu*; Wang, Jun*Biomaterials, 2023, 302: 122339.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
ACS Nano
发表日期
2023-05-03
卷期
第 17 卷, 第 10 期
页码
8966-8979
DOI
10.1021/acsnano.2c08240
语言
ENGLISH
成果收录
SCIE
资助标注
National Key R&D Program of China [2022YFC3401400, 2022YFB3804600]; National Nat- ural Science Foundation of China [52173122, 51922043]; Guangdong Basic and Applied Basic Research Foundation [2022B1515120028]; Science and Technology Planning Project of Ganzhou [202101074816]; Fundamental Research Funds for the Central Universities

作者

  • L

    Luo, Jia-Qi (第一作者)

  • L

    Liu, Rong

查看全部 7 位作者收起作者
  • C

    Chen, Fang-Man

  • Z

    Zhang, Jing-Yang

  • Z

    Zheng, Sui-Juan

  • S

    Shao, Dan

  • D

    Du, Jin-Zhi (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417